GENERALPRACTICE UseofvitaminB-12inLeicestershirepractices:asingletopicaudit ledbyamedicalauditadvisorygroup RobinCFraser,AzharFarooqi,RozSorrie Abstract Objectives-Toencourageactiveparticipationof Leicestershiregeneralpractitionersandtheirstaffin audit;toeminetheuseofvitaminB-12injections andtoachieveamoreappropriateuse.Design-Implementation ofanagreedaudit protocol,withcentralanalysisandfeedbackof anonymousandaggregateddatabyamedicalaudit advisorygroup.Setting-All147Leicestershirepractices.Mainoutcomemeasures-Participation inthe completeauditcycle,comparisonofactualuseof vitaminB-12injectionswithagreedcriteriaofuse, andassessmentofimprovementinuse.
Results-264generalpractitioners(55%ofall doctorsfrom49Z/oofallLeicestershirepractices) completedbothphasesoftheauditcycle,and321 (67%/6)completedphase1only.Twentyfour(16%/.) practicesfailedtoparticipatefromtheoutset,anda further58(35Z/6)droppedoutatvariousstages.Only 10ofthe37singlehandedpracticescompletedthe audit,although34initiallyagreedtoparticipate.If singlehandedpracticeswereexcluded,56%/(61)of practicescompletedbothphasesoftheauditcycle. Intotal1714patientsreceivedB-12injections.Appropriateuseincreasedfrom62%inphase1to 72%/inphase2oftheaudit;therewasa32% reductioninthenumberofpatientsinappropriately receivingB-12(521to352),andtheproportionof patientsreceivingB-12atthecorrectfrequencyrose from58%to72%/.Theproportionofpatientsin whomallthediagnosticcriteriaforpernicious anaemiawereestablishedbeforetreatmentwith B-12was27%/inphase1and28%/inphase2.
Conclusion-Ourstudysuggeststhatsingletopic auditsorganisedbyamedicalauditadvisorygroup canencouragelargenumbersofgeneralprac- titionerstoparticipateandcanbringaboutchanges inbehaviourresultinginimprovementsinstandards ofcare.Nevertheless,advisorygroupswillneedto devisestrategiestoencourageevenhigherlevelsof involvement,mostparticularlyfromsinglehanded practices. LeicestershireMedical AuditAdvisoryGroup, DepartentofGeneral Practice,Universityof Leicester,Leicester GeneralHospital, LeicesterLES4PW RobinCFraser,professorof generalpractice AzharFarooqi,seniorclinical researchfeow RozSome,seniormedical auditliaisonofficer Correspondenceto: ProfessorFraser.
BM31995;311:28-30Introduction Medicalauditadvisorygroupsweregiventhetaskof ensuringthatallgeneralpractitionerswerepartici- patinginmedicalauditbyApril1992.'Althoughmost generalpractitionersregardauditaseffectivein improvingthequalityofpatientcareandarewillingto participate,actualparticipationinauditislow,andof thosewhodoparticipateonlyaminoritycompletethe cycleofaudit.23Accordingly,theLeicestershire MedicalAuditAdvisoryGroupdecidedtoinviteall practicesinLeicestershiretoparticipateinasingle topicauditwhosegeneralaimswereto: *Encourageactiveparticipationofallgeneralprac- titionersandtheirstaffinaclinicalaudit*Familiarisegeneralpractitionersandmembersof theprimaryhealthcareteamwiththepracticalities entailedincompletingtheauditcycle *Demonstratetoparticipantsthefeasibilityand utilityofclinicalaudit *Stimulatepracticestoinitiatetheirownfutureaudit exercises.
TheuseofvitaminB-12injectionswasselectedas theparticulartopicforseveralreasons.Wethoughtit advisabletostartwitharelativelysimpleauditas participationwasprobablythefirstexperienceofaudit formanypractices.Wealsoanticipatedthatmost practicescouldcopewiththeexpectedsmallworkload, althoughsomechangeinclinicalbehaviourwouldbe required.'5Theauditwouldalsoentailmedical, nursing,andclericalmembersofprimarycarehealth teams.6Finally,alocallydevelopedprotocolwas alreadyavailable.7 Thespecificaimswere,firstly,toexaminetheuseof vitaminB-12injectionsinallLeicestershirepractices; and,secondly,toachievemoreappropriateand efficientuse. Method AllLeicestershirepractices(n=147)receivedpostal invitationstoparticipate.Non-respondentswere contactedbytelephone,andsomewerevisitedin responsetoinvitationsforfurtherinformationand explanation.Allpractitionerswithinapartnershiphad toagreetoparticipationbeforeapracticewouldbe accepted.
Participatingpracticesidentifiedpatientswhowere receivingB-12injectionsbyreferencetocomputerised ormanualsystemsforrepeatprescriptionsandalsoby personalrecollectionbythemembersoftheprimary healthcareteam.Patients'recordswerethenreviewed toidentifyreasonsfortheuseofvitaminB-12andthe extenttowhichdiagnosticcriteriawereestablishedand appropriatemanagementandfollowupundertaken. Alldetailswereenteredonaspeciallydesignedform, andcompletedformswerereturnedtothemedical auditadvisorygroupforanalysis.Individualpractices weresenttheirinitialresultsandanonymouscom- parativedatafromallparticipatingpractices(months Ito6).Anopenmeetingwasthenheld(month7)topresent anddiscussaggregatedresultsofthefirstphaseandto considerandagreesuggestedcriteriafortheuseof vitaminB-12(seebelow)beforeimplementationof change.
Participantswerethengiventimetoimplement necessarychangebeforethesecondphaseofdata collection(months7to15).Practicesagainreturned theirindividualresultstothemedicalauditadvisory groupforanalysisandreceivedafurtherpersonalised analysisofresultsandcommentary(months16to20). Asecondopenmeetingwassubsequentlyheldto discussoverallresults(month21).Criteriaofaccepted BMJVOLUME3111juLY1995 practiceagainstwhichperformancewasjudgedwere devised(box).
Results TableIshowsthat123(84%)ofallLeicestershire practicesinitiallyagreedtoparticipateintheaudit, witharangeof80%(twoorthreepartnerpractices)to 92%(singlehandedpractices).Ninetytwo(63%)prac- ticescompletedthefirstphasewithagradientfrom 46%(singlehandedpractices)to79%(fourorfive principals).Intotal321generalpractitioners(repre- senting67%ofallLeicestershiregeneralpractitioners) completedthefirstphase,and264generalpracti- tioners(55%)completedbothphasesoftheaudit withinthetimetableoftheproject.Although92%(34) ofsinglehandedpractitionersinitiallyagreedtopartici- pate,only27%(10)completedbothphasesofthe audit.Ifweexcludesinglehandedpractices,560/o(62) ofLeicestershirepracticescompletedbothphasesof theauditcycle.(Threemorepracticescompletedthe auditafterthedeadlinebutwerenotincludedinthis analysis.) TableIIshowsthereasonsfortheuseofvitamin B-12.InphaseIhalfofthepatientswerereceivingitas replacementtreatmentforperniciousanaemia;this roseto61%inphase2.Therewasa32%reductionin thenumberofpatientsreceivingB-12fornon-valid reasons(from521to352).TableIIIshowsthemost commonnon-validreasons.
TableIVshowsthatasimilarminorityofpatients hadallthreediagnosticcriteriaforperniciousanaemia establishedbeforestartingtreatmentwithvitamin B-12inbothphases(27%v28%).Formorethantwo thirdsofpatients,however,twoormorediagnostic criteriaforpemiciousanaemiahadbeenestablished. Theabsolutenumbersofpatients(n=52)receiving vitaminB-12withoutpreviousestablishmentofany diagnosticcriteriawasreducedto12inphase2, althoughtherelativeproportionswereunchanged (8%v9%).Ofthe1350patientsreceivingvitaminB-12inphase 1,overhalf(58%)hadtherecommendedfrequencyof injectionsof12weeks,risingto72%inphase2(table V).Theproportionofpatientswithfrequenciesof injectionsofeightweeksorlessdroppedfrom28%to 16%.Elevenpercentofpatientscontinuedtoreceiveinjectionsatintervalsoflessthanfiveweeks.Overall, 54%and610%ofpatientshadabloodcountperformed withinoneyearinphases1and2,respectively, although9%and6%hadnothadabloodcountdone forsixyearsormore.
Theproportionsofpatientsreceivingtheirinjec- tionsatpracticepremisesorathomeremained TABLEI-PracticeparticipationinauditofvitaminB-12bysizeof partnership.Figuresarenumbers(percentages) Practices PracticesizeAllinitiallyPracticesPractices (NoofLeicestershireagreeingtocompletingcompleting principals)practicesparticipate1stphasebothphases 13734(92)17(46)10(27) 2-35443(80)34(63)28(52) 4-53832(84)30(79)24(63) a_:,61815(83)11(61)10(56) Totals147124(84)92(63)72(49) TABLEn-ReasonsforuseofB-12injections.Figuresarenumbers (percentages)ofpatients Practicescompletingboth Practicesphases completing Reasonsforusephase1onlyPhase1Phase2 Perniciousanaemia865(51)671(50)780(61) Aftersurgeryandmalabsorption 195(11)158(12)148(11) Non-validreasons654(38)521(38)352(28) Totals 1714(100)1350(100)1280(100) TABLEm-Non-validreasonsfortheuseofvitaminB-12.Figuresare numbers(percentages)ofpatients PracticesPracticescompletingbothphases completing Reasonsforusephase1onlyPhase1Phase2 Noreasonfound167(26)128(25)56(16) "Vegetarian"/poordiet143(22)106(20)69(20) IsolatedlowserumB-12 concentration 63(10)62(12)62(18) Debility/"tonic" 49(7)43(8)21(6) Multiplesclerosis43(6)36(7)30(8) Diabetes 21(3)14(3)9(2) Otherreasons168(26)132(25)105(30) Totals 654(100)521(100)352(100) TABLEtv-Establishingdiagnosticcriteriaforperniciousanaemia.
Figuresarenumbers(percentages)ofpatients Practicescompletingbothphases Practices Diagnosticcriteriacompleting Phase2 established phase1onlyPhase1(newcasesonly) Threecriteria225(26)179(27)39(28) Twocriteria420(49)318(47)67(49) Onecriterion157(18)122(18)20(14) Nocriteria63(7)52(8)12(9) Totals 865(100)671(100)138(100) TABLEv-FrequencyofinjectionsofvitaminB-12.Figuresare numbers(percentagesofpatients) PracticesPracticescompletingbothphases Frequencyofcompleting injections(weeks)phase1onlyPhase1Phase2 1-3 52(3)38(3)32(2.5) 4 276(16)218(16)106(85) 5-8 158(9)115(9)66(5) 9-11 12(1)9(1)6(0-5) 12 1006(59)788(58)923(72) a13179(10)155(11)139(11) Notknown 31(2)27(2)8(05) Totals1714(100)1350(100)1280(100) BMJVOLUME3111JuLY1995Criteriaofacceptedpractice UseofvitaminB-12injections *Ofprovedvalueinthetreatmentofpernicious anaemia(otherconditionsbeingrareingeneralprac- ticeintheUnitedKingdom) *Maybenecessaryincertainstatesaftersurgeryand inmalabsorption-forexample,gastrectomy,resec- tionofterminalileum,andcoeliacdisease Diagnosticcriteriaforperniciousanaemia Theremustbeevidenceof: *Macrocyticanaemia *LowserumB-12concentrationwithnormalfolate concentration *AreticulocyteresponsetoB-12injections Criteriafortreatmentandmanagement *Optimummaintenancedoseis1000,utgatintervals of12weeks *Followupannualbloodcountisrequiredtoavoid relapse Operationalefficiency *Anurseshouldgiveallnecessaryinjections *Theinjectionsshouldbegivenatahealthcentreor surgeryifpossible 29 unchangedinbothphases:67%v69'5%and29%v 27%,respectively.Fewerthan190(1410/o)venues wereconsideredinappropriate.Nursesgavetheinjec- tionsonnearlyalloccasions(91%v93%).Sevenper centofinjections,however,weregivenbyadoctorin phase1,reducingto5%inphase2.
Discussion Essentially,theLeicestershireMedicalAudit AdvisoryGrouphadthetwinaimsofencouraging generalpractitionerstoparticipateinauditandeffect- ingimprovementsintheuseofvitaminB-12.Toa considerableextentbothwereachieved.
LEVELSOFPARTICIPATION Wehaveshownthatamedicalauditadvisorygroup canstimulatelargenumbersofpractitionerstotake partinmedicalauditasgeneralpractitioners,repre- sentingoverhalfofallLeicestershiregeneralpracti- tioners,completedtheauditcycle.Furthermore,321 doctors,representing67%ofallLeicestershiregeneral practitioners,completedphase1oftheaudit.This comparesfavourablywiththeresultsofoursurveyof Leicestershirepracticesin1991(whenthemedical auditadvisorygroupwasfirstconstituted),which showedthatonly40%ofrespondinggeneralprac- titionershadtakenparteveninpartialaudit.8 Ontheotherhand,16%ofLeicestershirepractices failedtoparticipateintheauditfromtheoutsetanda further35%ofpracticesdroppedoutatvariousstages oftheauditcycle.Anticipatingsuchnon-participation anddefections,wehadcommissionedtheEliLilly NationalClinicalAuditCentretocarryoutan independent,prospectivestudytoidentifythepar- ticularreasonsandtoinformfuturegroupstrategy.9It isevident,however,thatsinglehandedpracticeswill requirepracticalsupportasonlyaboutaquarter completedbothphasesoftheaudit,althoughnearlyall hadoriginallyagreedtoparticipate.
Nevertheless,itseemsthatasingletopicaudit organisedbyanauditadvisorygroupisauseful methodforfamiliarisinglargenumbersofgeneral practitionerswiththepracticalitiesofmedicalaudit. Astheauditwasrelativelyuncomplicated,entailingan averageof20patientsperpractice,itremainstobeseen whetherthiswill"changetheculture"andencourage greaterinvolvementinselfinitiatedauditinthefuture.Itisencouraging,however,that194generalpracti- tioners,representing40%ofallLeicestershiregeneral practitioners,arecurrentlyparticipatinginoursecond singletopicauditondiabetes,whichisamuch moredemandingactivitiy.Notwithstanding,advisory groupswillneedtocontinuetoseekwaystoencourage involvementinauditbythecurrentnon-participants, mostparticularlysinglehandedpractices.
Keymessages *Medicalauditadvisorygroupsweresetupwiththespecificremitofensuring participationinmedicalauditbygeneralpractitioners *Thegroupshaveusedvariousapproachestoencourageinvolvementin audit *Thisstudyshowsthatasingletopicauditledbysuchagroupcanencourage largenumbersofgeneralpractitionerstoparticipateinaudit *Italsoprovidesfurtherevidencethatparticipationinauditcanbring aboutchangeinclinicalbehaviourleadingtoimprovementsinstandards ofcare *Thesearchmustcontinueforwaysofinvolvingnon-participatinggeneral practitioners,especiallythosewhopracticesinglehandedlyCHANGESINTHEUSEOFVITAMINB-12 WhenweconsidertheuseofvitaminB-12thefirst datacollectionphaseincluded1714patientsreceiving B-12injectionsfromapopulationbaseof606000.
Consequently,thisstudyisthemostextensive assessmentoftheuseofvitaminB-12ingeneral practiceyetreported.Ithasconfirmedthefindings ofpreviousstudiesthatvitaminB-12isstillused inappropriately.4-7 Nevertheless,involvementintheauditstimulated considerablechangeinbehaviouramongparticipating doctors,leadingtosubsequentimprovementsintheir useofvitaminB-12.Forexample,theuseofvitamin B-12forcorrectreasonsimprovedby10%(62%in phase1to72%inphase2)resultingina32%reduction inthenumberofpatientsinappropriatelyreceivingit (521to352).Indeed,somepracticesachieveddramatic change:onepracticereducedthenumberofpatients onB-12injectionsfrom53tojusttwo,whereasothers achievedlittleornochange.Thereasonsforsucha variableresponsearebeyondthescopeofthisstudy. TheproportionofpatientsreceivingB-12injectionsat thecorrectfrequencyalsoincreasedby14%(58%to 72%),whichresultedinfewerpatientsreceiving unnecessaryinjections.
Ontheotherhand,theestablishmentofappropriate diagnosticcriteriaforperniciousanaemiabeforestart- ingtreatmentwithvitaminB-12remainedvirtually unchangedthroughout:27%inthefirstphasecom- paredwith28%inthenewlydiagnosedpatientsin phase2.Irrespectiveofwhetherpatientsarediagnosed ashavingperniciousanaemiaingeneralpracticeor hospital,itwouldseemessentialtoestablishsucha diagnosisonafirmbasisbeforeembarkingonlifelong treatmentofsuchpatients.Furthermore,almost40% ofpatientswerestillnotundergoinganannualblood count,14%ofpatientswerestillreceivingtheir injectionsininappropriatevenues,anddoctorswere stilladministering5%ofinjections.
CONCLUSION Althoughprovisionoffeedbackofresultsfrom individualpracticeswithcomparativedatafrompeers canbeapowerfultoolforencouragingpositivechanges inbehaviour,suchchangeisnotautomatic.Never- theless,ourresultssuggestthatsingletopicaudits organisedbyanauditadvisorygroupcanencouragea largenumberofgeneralpractitionerstotakepartand providefurtherevidencethatitcanalsobringabout changesinclinicalbehaviourleadingtoimprovements instandardsofcare.'0 Weacknowledgethecooperationreceivedfromthemany participatingdoctorsandpracticestaff.Thestudywas supportedbyagrantfromtheDepartmentofHealth. 1DepartmentofHealth.Medicalauditinthefamilypractitionerservices.London: DoH,1990.(HealthCircularHC(FP)(90)8.) 2DerryJ,LawrenceM,GriewK,AndersonJ,HumphreysJ,PandkerKS.Auditingaudits:themethodofOxfordshireMedicalAuditAdvisoryGroup.BMJ1991;303:1247-9.3WebbSJ,DowellAC,HeywoodP.SurveyofgeneralpracticeauditinLeeds.BM31991;302:390-2.
4CochraneA,MooreF.Expectedandobservedvaluesfortheprescriptionof vitaminB12inEnglandandWales.BritishJournalofPreventiveandSocial Medicine1971;25:147-51. 5EllisF,NasserS,WrightonRJ.AsurveyoftheuseofvitaminB12ingeneral practice.Practitioner1970;204:838.6MiddletonJ,WellsW.VitarninB12injections:considerablesourceofworkfor thedistrictnurse.EMY1985;290:1254-355.7FraserRC,CathcartM,SeivewfrightH.AuditoftheuseofvitaminB12in generalpractice.BMJ1983;287:729-31.8WilsonA,FraserRC,FarooqiA,ShapiroJ.MedicalauditinLeicestershire 1982-1991.Frominnovationtomainstreamactivity.AulditTrend,1994;2: 97-100.9BakerRH,FarooqiA,RobertsonN.Auditingeneralpractice:factors influencingparticipation.BMJ1995;311:31-4.10HoldenJD,HughesIM,TreeA,Benzodiazepineprescribingandwithdrawal for3234patientsin15generalpractices.FansPrac1994;1l:358-62.(Accepted9May1995) 30 BMJvoLum3111juLy1995
